LeserbriefKommentar
Subretinal Gene Therapy in X-Linked Retinoschisis
New England Journal of Medicine · 12.11.2026 · 395 (19) · 1970-1972
DOI: 10.1056/nejmc2609517 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 12.11.2026. Verfasst von Yang Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Ophthalmology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
- State Key Laboratory of Eye Health, National Clinical Center for Ocular Diseases, National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Yang, Y., Zhang, K., & Lu, F. (2026). Subretinal Gene Therapy in X-Linked Retinoschisis. New England Journal of Medicine, 395(19), 1970-1972. https://doi.org/10.1056/nejmc2609517
Vancouver
Yang Y, Zhang K, Lu F. Subretinal Gene Therapy in X-Linked Retinoschisis. New England Journal of Medicine. 2026;395(19):1970-1972. doi:10.1056/nejmc2609517
BibTeX
@article{Yang2026,
author = {Yang, Yang and Zhang, Kang and Lu, Fang},
title = {Subretinal Gene Therapy in X-Linked Retinoschisis},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {19},
pages = {1970--1972},
doi = {10.1056/nejmc2609517}
}
EUVIMED